First Trust Advisors’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

First Trust Advisors’s Portfolio SCMP Stock Details SCMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-22,543	Closed	-$405K	–	2465
2017 Q4	$405K	Buy	22,543 +2,685	+14%	+$33.1K	﹤0.01%	2156
2017 Q3	$234K	Sell	19,858 -145	-0.7%	-$1.63K	﹤0.01%	2293
2017 Q2	$210K	Sell	20,003 -449	-2%	-$4.58K	﹤0.01%	2278
2017 Q1	$225K	Sell	20,452 -7,372	-26%	-$85.6K	﹤0.01%	2285
2016 Q4	$377K	Buy	27,824 +5,167	+23%	+$72.1K	﹤0.01%	2216
2016 Q3	$279K	Buy	+22,657	New	+$267K	﹤0.01%	2159

Other funds holding SCMP

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

First Trust Advisors's SCMP Position: Q1 2018 in Review

First Trust Advisors sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 22,543 shares — an estimated $405K sold.

First Trust Advisors first reported a position in SCMP in Q3 2016 and held it in 6 quarters. The position peaked at $405K in Q4 2017. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

First Trust Advisors reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
First Trust Advisors sold 22,543 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $405K.
First Trust Advisors first reported a position in Sucampo Pharmaceuticals, Inc. in Q3 2016 and held it in 6 quarters.
First Trust Advisors's Sucampo Pharmaceuticals, Inc. position peaked at $405K in Q4 2017.
3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on First Trust Advisors's 13F filing for Q1 2018, filed 23 Apr 2018.